Copyright
©The Author(s) 2022.
World J Clin Cases. Mar 26, 2022; 10(9): 2783-2791
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2783
Published online Mar 26, 2022. doi: 10.12998/wjcc.v10.i9.2783
Figure 1 Representative immunohistochemical staining for Ubiquilin4 expression in cervical cancer specimens.
A and B: High expression of Ubiquilin4 (UBQLN4) in cervical cancer, score: 3; C and D: Low expression of UBQLN4 in cervical cancer, score: 2; E and F: Low expression of UBQLN4 in paracervical tissue, score: 1; G and H: Low expression of UBQLN4 in paracervical tissue, score: 0. (A, C, E, and G: Original magnification, 100 ×; B, D, F, and G: Original magnification, 200 ×).
- Citation: Wang LN, Huang KJ, Wang L, Cheng HY. Overexpression of Ubiquilin4 is associated with poor prognosis in patients with cervical cancer. World J Clin Cases 2022; 10(9): 2783-2791
- URL: https://www.wjgnet.com/2307-8960/full/v10/i9/2783.htm
- DOI: https://dx.doi.org/10.12998/wjcc.v10.i9.2783